SILVERARC CAPITAL MANAGEMENT, LLC Terns Pharmaceuticals, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$85,000
portfolio value

Terns Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 14.47K shares 85K $5.89 14.47K